Free Trial

WORK Medical Technology Group (WOK) Competitors

$0.79 +0.01 (+0.64%)
Closing price 08/14/2025 04:00 PM Eastern
Extended Trading
$0.78 -0.01 (-0.70%)
As of 08/14/2025 04:01 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

WOK vs. SGHT, CVRX, INGN, PROF, TLSI, ELMD, LNSR, KRMD, PDEX, and RCEL

Should you be buying WORK Medical Technology Group stock or one of its competitors? The main competitors of WORK Medical Technology Group include Sight Sciences (SGHT), CVRx (CVRX), Inogen (INGN), Profound Medical (PROF), TriSalus Life Sciences (TLSI), Electromed (ELMD), LENSAR (LNSR), KORU Medical Systems (KRMD), Pro-Dex (PDEX), and Avita Medical (RCEL). These companies are all part of the "medical equipment" industry.

WORK Medical Technology Group vs. Its Competitors

Sight Sciences (NASDAQ:SGHT) and WORK Medical Technology Group (NASDAQ:WOK) are both small-cap medical companies, but which is the superior business? We will contrast the two companies based on the strength of their dividends, valuation, profitability, institutional ownership, media sentiment, earnings, risk and analyst recommendations.

In the previous week, Sight Sciences had 9 more articles in the media than WORK Medical Technology Group. MarketBeat recorded 10 mentions for Sight Sciences and 1 mentions for WORK Medical Technology Group. WORK Medical Technology Group's average media sentiment score of 1.87 beat Sight Sciences' score of 0.83 indicating that WORK Medical Technology Group is being referred to more favorably in the news media.

Company Overall Sentiment
Sight Sciences Positive
WORK Medical Technology Group Very Positive

55.5% of Sight Sciences shares are owned by institutional investors. 30.9% of Sight Sciences shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock will outperform the market over the long term.

Sight Sciences presently has a consensus target price of $4.27, indicating a potential upside of 0.39%. Given Sight Sciences' stronger consensus rating and higher possible upside, analysts plainly believe Sight Sciences is more favorable than WORK Medical Technology Group.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Sight Sciences
0 Sell rating(s)
4 Hold rating(s)
3 Buy rating(s)
0 Strong Buy rating(s)
2.43
WORK Medical Technology Group
0 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
0.00

WORK Medical Technology Group has lower revenue, but higher earnings than Sight Sciences.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Sight Sciences$79.87M2.79-$51.51M-$0.96-4.43
WORK Medical Technology Group$11.51M3.86-$3.49MN/AN/A

WORK Medical Technology Group has a net margin of 0.00% compared to Sight Sciences' net margin of -64.23%. WORK Medical Technology Group's return on equity of 0.00% beat Sight Sciences' return on equity.

Company Net Margins Return on Equity Return on Assets
Sight Sciences-64.23% -59.38% -36.43%
WORK Medical Technology Group N/A N/A N/A

Summary

Sight Sciences beats WORK Medical Technology Group on 7 of the 13 factors compared between the two stocks.

Get WORK Medical Technology Group News Delivered to You Automatically

Sign up to receive the latest news and ratings for WOK and its competitors with MarketBeat's FREE daily newsletter.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding WOK and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

WOK vs. The Competition

MetricWORK Medical Technology GroupMED INSTRUMENTS IndustryMedical SectorNASDAQ Exchange
Market Cap$44.12M$7.00B$5.61B$9.84B
Dividend YieldN/A1.30%4.61%4.07%
P/E RatioN/A25.4830.2925.74
Price / Sales3.8673.48463.41115.83
Price / CashN/A21.9738.2159.48
Price / Book0.715.388.826.15
Net Income-$3.49M$176.29M$3.25B$265.06M
7 Day Performance-1.24%3.21%3.70%2.60%
1 Month Performance0.71%1.49%5.84%2.83%
1 Year PerformanceN/A10.20%29.92%25.58%

WORK Medical Technology Group Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
WOK
WORK Medical Technology Group
N/A$0.79
+0.6%
N/AN/A$44.12M$11.51M0.00226Positive News
Gap Up
SGHT
Sight Sciences
1.6664 of 5 stars
$3.49
+0.6%
$3.93
+12.7%
-26.6%$180.43M$79.87M-3.56210
CVRX
CVRx
2.8303 of 5 stars
$6.80
-9.9%
$14.00
+105.9%
-9.2%$177.28M$51.29M-3.12160High Trading Volume
INGN
Inogen
4.387 of 5 stars
$6.33
-3.2%
$11.00
+73.8%
-37.0%$170.20M$339.96M-5.501,030
PROF
Profound Medical
2.691 of 5 stars
$5.58
-1.9%
$11.00
+97.1%
-40.5%$167.68M$10.68M-4.57150News Coverage
Earnings Report
TLSI
TriSalus Life Sciences
3.0474 of 5 stars
$4.21
+0.2%
$10.75
+155.3%
-33.7%$159.30M$32.14M-3.76106News Coverage
Earnings Report
ELMD
Electromed
1.0697 of 5 stars
$18.61
-0.1%
$33.50
+80.0%
+33.6%$156.06M$61.44M24.81160
LNSR
LENSAR
0.6599 of 5 stars
$13.04
+0.8%
$15.00
+15.0%
+211.7%$153.74M$53.49M-2.69110
KRMD
KORU Medical Systems
1.9411 of 5 stars
$3.28
-3.0%
$4.63
+41.0%
+78.4%$151.34M$33.65M-29.8280Positive News
PDEX
Pro-Dex
3.2549 of 5 stars
$45.09
-1.4%
$56.00
+24.2%
+118.1%$146.99M$53.84M16.10140Positive News
RCEL
Avita Medical
1.4572 of 5 stars
$5.28
-1.3%
$16.50
+212.5%
-35.5%$139.55M$64.25M-2.41130

Related Companies and Tools


This page (NASDAQ:WOK) was last updated on 8/15/2025 by MarketBeat.com Staff
From Our Partners